Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.590
+0.070 (2.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $57.75 million as of December 20, 2024.
Market Cap
57.75M
Enterprise Value
-109.26M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $57.75M, a decrease of -83.77%. That is a compound annual growth rate of -91.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 57.75M | -83.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pheton Holdings | 59.42M |
| Apyx Medical | 59.10M |
| Scilex Holding Company | 58.95M |
| DBV Technologies | 58.11M |
| Kronos Bio | 57.80M |
| LakeShore Biopharma | 56.48M |
| Serina Therapeutics | 56.35M |
| Xilio Therapeutics | 56.27M |